69958-52-7 Usage
Uses
Used in Pharmaceutical Research:
3-Amino-5,6,7,8-tetrahydroisoquinoline is used as a precursor in the synthesis of various biologically active compounds for pharmaceutical applications. Its unique structure and potential pharmacological properties make it a promising candidate for the development of new drugs.
Used in Central Nervous System Applications:
3-Amino-5,6,7,8-tetrahydroisoquinoline is used as a research compound for studying its activity in the central nervous system. Its potential effects on neurological processes and disorders are of interest to scientists working in the field of neuroscience and drug development.
Used in Synthetic Chemistry:
3-Amino-5,6,7,8-tetrahydroisoquinoline is used as a key intermediate in synthetic chemistry for the preparation of complex organic molecules and pharmaceutical agents. Its versatile structure allows for various chemical modifications, facilitating the creation of novel compounds with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 69958-52-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,9,5 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 69958-52:
(7*6)+(6*9)+(5*9)+(4*5)+(3*8)+(2*5)+(1*2)=197
197 % 10 = 7
So 69958-52-7 is a valid CAS Registry Number.
69958-52-7Relevant academic research and scientific papers
Α 7 as intranuclear hydroxynicotinic acetylcholine receptor quinuclidines compd.
-
Paragraph 0698; 0699, (2018/10/03)
PROBLEM TO BE SOLVED: To provide ligands for the nicotinic α-7 receptor used for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.SOLUTION: The disclosure provides compounds of the specified formula I, including their salts, and compositions and methods using the compounds.
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
-
, (2008/06/13)
Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. STR1
